1. Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer;Sparano;J. Clin. Oncol.,2001
2. Nanoliposomes for doxorubicin delivery: reversing drug resistance, stimuli-responsive carriers and clinical translation;Hashemi;J. Drug Deliv. Sci. Technol.,2023
3. Nano)platforms in bladder cancer therapy: challenges and opportunities;Ashrafizadeh;Bioeng Transl Med,2023
4. Biomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applications;Jan;Bioeng Transl Med,2022
5. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugate;Yoo;J. Contr. Release,2004